Steven Cohen Novavax Inc Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Novavax Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 304,800 shares of NVAX stock, worth $3.61 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
304,800
Previous 204,800
48.83%
Holding current value
$3.61 Million
Previous $983,000
48.12%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NVAX
# of Institutions
244Shares Held
76.1MCall Options Held
5.06MPut Options Held
7.19M-
State Street Corp Boston, MA16.9MShares$200 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$160 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.43MShares$112 Million0.0% of portfolio
-
Shah Capital Management8.12MShares$96.1 Million19.75% of portfolio
-
Geode Capital Management, LLC Boston, MA2.59MShares$30.6 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $926M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...